Machine learning techniques for in silico modeling of drug metabolism.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Current Topics in Medicinal Chemistry

• Publication date

  2006-07-31

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.2174/156802606778108915PMID 16918470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Greater than the sum of its parts: combining models for useful ADMET prediction.

  2005cited by this paper
• Prediction of Cytochrome P450 3A4, 2D6, and 2C9 Inhibitors and Substrates by Using Support Vector Machines

  2005cited by this paper
• Development of CYP3A4 Inhibition Models: Comparisons of Machine-Learning Techniques and Molecular Descriptors

  2005cited by this paper
• Do Fukui Function Maxima Relate to Sites of Metabolism? A Critical Case Study

  2005cited by this paper
• Cytochrome p450 in silico: an integrative modeling approach.

  2005cited by this paper
• A rapid computational filter for cytochrome P450 1A2 inhibition potential of compound libraries.

  2005cited by this paper
• A support vector machine approach to classify human cytochrome P450 3A4 inhibitors

  2005cited by this paper
• MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist.

  2005cited by this paper
• Structure-Based Methods for the Prediction of the Dominant P450 Enzyme in Human Drug Biotransformation: Consideration of CYP3A4, CYP2C9, CYP2D6

  2005cited by this paper
• Mining High-Throughput Screening Data of Combinatorial Libraries: Development of a Filter to Distinguish Hits from Nonhits

  2004cited by this paper
• QUANTITATIVE STRUCTURE-METABOLISM RELATIONSHIP MODELING OF METABOLIC N-DEALKYLATION REACTION RATES

  2004cited by this paper
• Rapid prediction of chemical metabolism by human UDP-glucuronosyltransferase isoforms using quantum chemical descriptors derived with the electronegativity equalization method.

  2004cited by this paper
• QSAR of Cytochrome P450

  2004cited by this paper
• Ensemble Methods for Classification in Cheminformatics

  2004cited by this paper
• Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.

  2004cited by this paper
• Classification of kinase inhibitors using a Bayesian model.

  2004cited by this paper
• KOHONEN MAPS FOR PREDICTION OF BINDING TO HUMAN CYTOCHROME P450 3A4

  2004cited by this paper
• Predicting human drug glucuronidation parameters: application of in vitro and in silico modeling approaches.

  2004cited by this paper
• Can the pharmaceutical industry reduce attrition rates?

  2004cited by this paper
• Generation of QSAR sets with a self-organizing map.

  2004cited by this paper
• Early prediction of drug metabolism and toxicity: systems biology approach and modeling.

  2004cited by this paper
• Molecular Similarity Searching Using Atom Environments, Information-Based Feature Selection, and a Naïve Bayesian Classifier

  2004cited by this paper
• In silico methods for predicting ligand binding determinants of cytochromes P450.

  2004cited by this paper
• Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.

  2003cited by this paper
• Development and validation of k-nearest-neighbor QSPR models of metabolic stability of drug candidates.

  2003cited by this paper
• In silico approaches to predicting drug metabolism, toxicology and beyond.

  2003cited by this paper
• Use of Robust Classification Techniques for the Prediction of Human Cytochrome P450 2D6 Inhibition

  2003cited by this paper
• Comparison of Linear and Nonlinear Classification Algorithms for the Prediction of Drug and Chemical Metabolism by Human UDP-Glucuronosyltransferase Isoforms

  2003cited by this paper
• Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9.

  2003cited by this paper
• Generation and validation of rapid computational filters for cyp2d6 and cyp3a4.

  2003cited by this paper
• ADMET in silico modelling: towards prediction paradise?

  2003cited by this paper
• Prediction of Aqueous Solubility of Organic Compounds Based on a 3D Structure Representation

  2003cited by this paper
• Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling

  2003cited by this paper
• A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules.

  2003cited by this paper
• Computational models for cytochrome P450: a predictive electronic model for aromatic oxidation and hydrogen atom abstraction.

  2002cited by this paper
• A comparison of methods for multiclass support vector machines

  2002cited by this paper
• A neural network based virtual screening of cytochrome P450 3A4 inhibitors.

  2002cited by this paper
• Differential modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1)-catalyzed estradiol-3-glucuronidation by the addition of UGT1A1 substrates and other compounds to human liver microsomes.

  2002cited by this paper
• Pyrene.pyrene complexes at the active site of cytochrome P450 3A4: evidence for a multiple substrate binding site.

  2002cited by this paper
• The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans.

  2002cited by this paper
• Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1.

  2002cited by this paper
• Pharmacophore modeling of cytochromes P450.

  2002cited by this paper
• Computer systems for the prediction of xenobiotic metabolism.

  2002cited by this paper
• Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.

  2002cited by this paper
• An introduction to kernel-based learning algorithms

  2001cited by this paper
• Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism.

  2001cited by this paper
• Prediction of Hepatic Metabolic Clearance

  2001cited by this paper
• (Q) SAR study on the metabolic stability of steroidal androgens.

  2001cited by this paper
• Pharmacophore and three-dimensional quantitative structure activity relationship methods for modeling cytochrome p450 active sites.

  2001cited by this paper
• Pharmacophore modeling and three-dimensional database searching for drug design using catalyst.

  2001cited by this paper
• Application of in silico approaches to predicting drug--drug interactions.

  2001cited by this paper
• Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity.

  2001cited by this paper
• Search for Predictive Generic Model of Aqueous Solubility Using Bayesian Neural Nets

  2001cited by this paper
• Role of drug metabolism in drug discovery and development

  2001cited by this paper
• Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance.

  2000cited by this paper
• Use of Automatic Relevance Determination in QSAR Studies Using Bayesian Neural Networks

  2000cited by this paper
• In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model.

  2000cited by this paper
• UDP-glucuronosyltransferases.

  2000cited by this paper
• THE HUMAN CYP3A SUBFAMILY: PRACTICAL CONSIDERATIONS*

  2000cited by this paper
• X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3

  1999cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• Combining in vitro and in vivo pharmacokinetic data for prediction of hepatic drug clearance in humans by artificial neural networks and multivariate statistical techniques.

  1999cited by this paper
• Evaluation of atypical cytochrome P450 kinetics with two-substrate models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites.

  1998cited by this paper
• Artificial neural networks for computer-based molecular design.

  1998cited by this paper
• Data modelling with neural networks: Advantages and limitations

  1997cited by this paper
• Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.

  1997cited by this paper
• Predicting the cytochrome P450 mediated metabolism of xenobiotics.

  1993cited by this paper
• Statistics using neural networks: chance effects.

  1993cited by this paper
• Comparison of the predicted and observed secondary structure of T4 phage lysozyme.

  1975cited by this paper

• Amidoquinoline‐Isatin‐Linked 1,2,3‐Triazole: Selective Pb(II) Sensor and In Silico Biological Insights

  2025cites this paper
• Leveraging machine learning models in evaluating ADMET properties for drug discovery and development

  2025cites this paper
• Reexamining the acute toxicity of chloropicrin: Comprehensive estimation using in silico methods.

  2025cites this paper
• 7-Azaindole-pyridine linked 1,2,3-triazole for selective Cr(III) and Ce(III) ion sensing

  2025cites this paper
• Advancing QSAR models in drug discovery for best practices, theoretical foundations, and applications in targeting nuclear factor-κB inhibitors- A bright future in pharmaceutical chemistry

  2025cites this paper
• Machine learning for metabolomics research in drug discovery

  2023cites this paper
• Development of New Antimycobacterial Sulfonyl Hydrazones and 4-Methyl-1,2,3-thiadiazole-Based Hydrazone Derivatives

  2022cites this paper
• Application of Machine Learning Technology in the Prediction of ADME Related Pharmacokinetic Parameters.

  2022cites this paper
• Artificial Intelligence, Big data and Machine Learning approaches in Preci-sion Medicine & Drug Discovery.

  2021cites this paper
• Predicting blood-to-plasma concentration ratios of drugs from chemical structures and volumes of distribution in humans

  2021cites this paper
• Trends in predictive biodegradation for sustainable mitigation of environmental pollutants: Recent progress and future outlook.

  2021cites this paper
• Trends in In Silico Approaches to the Prediction of Biologically Active Peptides in Meat and Meat Products as an Important Factor for Preventing Food-Related Chronic Diseases

  2021cites this paper
• A novel hybrid method named electron conformational genetic algorithm as a 4D QSAR investigation to calculate the biological activity of the tetrahydrodibenzazosines

  2020cites this paper
• Machine learning-driven new material discovery

  2020cites this paper
• Deep Learning Based Drug Metabolites Prediction

  2020cites this paper
• Tree-Based QSAR Model for Drug Repurposing in the Discovery of New Antibacterial Compounds against Escherichia coli

  2020cites this paper
• Machine Learning Approaches to Rational Drug Design

  2020cites this paper
• The significance of artificial intelligence in drug delivery system design.

  2019cites this paper
• In silico approaches and tools for the prediction of drug metabolism and fate: A review

  2019cites this paper
• Computational Prediction of the Isoform Specificity of Cytochrome P450 Substrates by an Improved Bayesian Method

  2019cites this paper
• Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.

  2019cites this paper
• Deep multiphysics: Coupling discrete multiphysics with machine learning to attain self-learning in-silico models replicating human physiology

  2019cites this paper
• DeepDock: Enhancing Ligand-protein Interaction Prediction by a Combination of Ligand and Structure Information

  2019cites this paper
• In-Silico Modeling in Drug Metabolism and Interaction: Current Strategies of Lead Discovery.

  2019cites this paper
• Current approaches for choosing feature selection and learning algorithms in quantitative structure–activity relationships (QSAR)

  2018cites this paper
• Construction of precise support vector machine based models for predicting promoter strength

  2017cites this paper
• Theoretical Studies of Intracellular Concentration of Micro-organisms’ Metabolites

  2017cites this paper
• Genomics and Artificial Intelligence Working Together in Drug Discovery and Repositioning: The Advent of Adaptive Pharmacogenomics in Glioblastoma and Chronic Arterial Inflammation Therapies

  2017cites this paper
• Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.

  2016cites this paper
• Improved Prediction of Michaelis Constants in CYP450-Mediated Reactions by Resilient Back Propagation Algorithm.

  2016cites this paper
• Use of machine learning approaches for novel drug discovery

  2016cites this paper
• In Silico ADMET Profiling

  2015cites this paper
• Prediction of Overall In Vitro Microsomal Stability of Drug Candidates Based on Molecular Modeling and Support Vector Machines. Case Study of Novel Arylpiperazines Derivatives

  2015cites this paper
• An improved large-scale prediction model of CYP1A2 inhibitors by using combined fragment descriptors

  2015cites this paper
• Quantitative Structure–Activity Relationship (QSAR) Methods for the Prediction of Substrates, Inhibitors, and Inducers of Metabolic Enzymes

  2014cites this paper
• Advancing Quantitative Structure Activity Relationship Strategies in Ligand-based Computer-aided Drug Design

  2014cites this paper
• Mass Spectrometry Based Identification of Geometric Isomers during Metabolic Stability Study of a New Cytotoxic Sulfonamide Derivatives Supported by Quantitative Structure-Retention Relationships

  2014cites this paper
• Ligand and Structure-Based Classification Models for Prediction of P-Glycoprotein Inhibitors

  2013influential citation
• Computational tools and resources for metabolism-related property predictions. 1. Overview of publicly available (free and commercial) databases and software.

  2012cites this paper
• Novel machine learning methods for computational chemistry

  2012cites this paper
• GPU-accelerated machine learning techniques enable QSAR modeling of large HTS data

  2012cites this paper
• Computational Prediction of Metabolism: Sites, Products, SAR, P450 Enzyme Dynamics, and Mechanisms

  2012cites this paper
• Integrative Systems Biology I—Biochemistry: Phase I Lead Discovery and Molecular Interactions

  2012cites this paper
• Paradigm Shift in Toxicity Testing and Modeling

  2012cites this paper
• Technology Review Special FocuS: compuTaTional chemiSTRy

  2012cites this paper
• Prediction of the functional consequences of single amino acid substitution in human cytochrome P450

  2012cites this paper
• Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug‐Like Molecules

  2012cites this paper
• Development and application of distributed computing tools for virtual screening of large compound libraries

  2012cites this paper
• Comparative Analysis of Machine Learning Techniques for the Prediction of the DMPK Parameters Intrinsic Clearance and Plasma Protein Binding

  2012cites this paper
• RS-Predictor: A New Tool for Predicting Sites of Cytochrome P450-Mediated Metabolism Applied to CYP 3A4

  2011cites this paper
• Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data

  2011cites this paper
• Application of ICA-CMAC in the Prediction of Human Hepatic Clearance

  2011cites this paper
• The Use of Computational Methods in the Toxicological Assessment of Chemicals in Food: Current Status and Future Prospects

  2011cites this paper
• Systematic generation of chemical structures for rational drug design based on QSAR models.

  2011cites this paper
• Application of electron conformational–genetic algorithm approach to 1,4-dihydropyridines as calcium channel antagonists: pharmacophore identification and bioactivity prediction

  2011cites this paper
• Ligand‐Based Virtual Screening

  2011cites this paper
• Comparative analysis of machine learning techniques for the prediction of logP

  2011cites this paper
• Advance Methodologies in Linear and Nonlinear Quantitative Structure-Activity Relationships (QSARs): from Drug Design to In Silico Toxicology Applications

  2010cites this paper
• Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability

  2010cites this paper
• Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.

  2010cites this paper
• Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage

  2010cites this paper
• Brainstorming: weighted voting prediction of inhibitors for protein targets

  2010cites this paper
• Review of QSAR Models and Software Tools for predicting Biokinetic Properties

  2010cites this paper
• Toward a comprehensive molecular design framework for reduced hazard.

  2010cites this paper
• Meta-heuristics on quantitative structure-activity relationships: study on polychlorinated biphenyls

  2010cites this paper
• Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.

  2010cites this paper
• Pharmaceutical Perspectives of Nonlinear QSAR Strategies

  2010cites this paper
• The applications of machine learning algorithms in the modeling of estrogen-like chemicals.

  2009cites this paper
• Bias-Correction of Regression Models: A Case Study on hERG Inhibition

  2009cites this paper
• Classification of Cytochrome P450 1A2 Inhibitors and Noninhibitors by Machine Learning Techniques

  2009cites this paper
• Interpretation of Nonlinear QSAR Models Applied to Ames Mutagenicity Data

  2009cites this paper
• Subgraphs of pair vertices

  2009cites this paper
• First-principle, structure-based prediction of hepatic metabolic clearance values in human.

  2009cites this paper
• Prediction of animal clearance using naïve Bayesian classification and extended connectivity fingerprints

  2009cites this paper
• Comparison of Multilabel and Single-Label Classification Applied to the Prediction of the Isoform Specificity of Cytochrome P450 Substrates

  2009cites this paper
• In silico prediction of drug properties.

  2009cites this paper
• Comparative analysis of machine learning methods in ligand-based virtual screening of large compound libraries.

  2009cites this paper
• The use of machine learning and nonlinear statistical tools for ADME prediction

  2009cites this paper
• Computational approaches to predict drug metabolism

  2009influential citation
• Multi‐Objective Feature Selection in QSAR Using a Machine Learning Approach

  2009cites this paper
• Considerations and recent advances in QSAR models for cytochrome P450-mediated drug metabolism prediction

  2008cites this paper
• Computational prediction of drug binding and rationalisation of selectivity towards cytochromes P450

  2008cites this paper
• and Non-Inhibitors by Machine Learning Techniques

  2008cites this paper
• How Long Will My Mouse Live? Machine Learning Approaches for Prediction of Mouse Life Span

  2008cites this paper
• Predicting human liver microsomal stability with machine learning techniques.

  2008cites this paper
• A Probabilistic Approach to Classifying Metabolic Stability

  2008cites this paper
• Calculated Molecular Properties and Multivariate Statistical Analysis

  2008cites this paper
• Microsoft Word-6960036-file00

  2008cites this paper
• Chapter 5 Linear Quantitative Structure–Activity Relationships for the Interaction of Small Molecules with Human Cytochrome P450 Isoenzymes

  2007cites this paper
• Improving Early Drug Discovery through ADME Modelling

  2007cites this paper
• Improving early drug discovery through ADME modelling: an overview.

  2007cites this paper
• Ligand-Based Models for the Isoform Specificity of Cytochrome P450 3A4, 2D6, and 2C9 Substrates

  2007cites this paper
• Lipidomics in drug and biomarker development

  2006cites this paper